Martin Edward Mäntylä Noble

1 Patent

• US120714292024

  Isoindolinone Inhibitors of the MDM2-P53 Interaction Having Anticancer Activity

  CANCER RESEARCH TECHNOLOGY LIMITED

  0 cites